Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
James R. Sherwood
Observed names:
J R Sherwood,
J. R. Sherwood,
James Sherwood,
James R. Sherwood,
Sherwood, James
Institution:
Takeda (Switzerland)
Observed institutions:
Cincinnati Children's Hospital Medical Center,
Takeda (Switzerland),
University of Cincinnati,
University of Cincinnati Medical Center
ORCID:
0009-0005-3448-4829
Observed ORCID:
0009-0005-3448-4829
OpenAlex ID:
A5085979449
Human Rotavirus Studies in Volunteers: Determination of Infectious Dose and Serological Response to Infection
1986
·
R. L. Ward
, D. I. Bernstein
, et al.
·
The Journal of Infectious Diseases
·
414
Effects of Antibody to Rotavirus on Protection of Adults Challenged with a Human Rotavirus
1989
·
R. L. Ward
, D. I. Bernstein
, et al.
·
The Journal of Infectious Diseases
·
143
Prevention of surface-to-human transmission of rotaviruses by treatment with disinfectant spray
1991
·
R L Ward
, D I Bernstein
, et al.
·
Journal of Clinical Microbiology
·
108
Clinical Activity of Pleconaril in an Experimentally Induced Coxsackievirus A21 Respiratory Infection
2000
·
Gilbert M. Schiff
, James R. Sherwood
·
The Journal of Infectious Diseases
·
88
Efficacy of an intramuscular bivalent norovirus GI.1/GII.4 virus-like particle vaccine candidate in healthy US adults
2020
·
James Sherwood
, Paul M. Mendelman
, et al.
·
Vaccine
·
86
Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A
1989
·
Peter D. Reuman
, David I. Bernstein
, et al.
·
Antiviral Research
·
85
Safety and Immunogenicity of Different Formulations of Norovirus Vaccine Candidate in Healthy Adults: A Randomized, Controlled, Double-Blind Clinical Trial
2017
·
Geert Leroux-Roels
, Jakob P Cramer
, et al.
·
The Journal of Infectious Diseases
·
73
PDF
Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents
1995
·
Gilbert M. Schiff
, James R. Sherwood
, et al.
·
Journal of Adolescent Health
·
53
Protection of Adults Rechallenged with a Human Rotavirus
1990
·
R. L. Ward
, D. I. Bernstein
, et al.
·
The Journal of Infectious Diseases
·
53
Persistence of Antibodies to 2 Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: 1-Year Follow-up With Memory Probe Vaccination
2019
·
Robert L Atmar
, Frank Baehner
, et al.
·
The Journal of Infectious Diseases
·
30
Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age: A phase 2 randomized, double-blind trial
2023
·
Pio López
, Eduardo López-Medina
, et al.
·
Human Vaccines & Immunotherapeutics
·
25
PDF
Ribavirin small-particle-aerosol treatment of influenza B virus infection
1988
·
D I Bernstein
, P D Reuman
, et al.
·
Antimicrobial Agents and Chemotherapy
·
23
Influenza-specific ELISA IgA and IgG predict severity of influenza disease in subjects prescreened with hemagglutination inhibition
1990
·
Peter D. Reuman
, David I. Bernstein
, et al.
·
Antiviral Research
·
19
Salivary antibody titers in adults challenged with a human rotavirus
1992
·
Richard L. Ward
, Kristine A. Pax
, et al.
·
Journal of Medical Virology
·
18
A Bivalent Human Norovirus Vaccine Induces Homotypic and Heterotypic Neutralizing Antibodies
2023
·
Robert L Atmar
, Khalil Ettayebi
, et al.
·
The Journal of Infectious Diseases
·
16
PDF
Differential effect of amantadine hydrochloride on the systemic and local immune response to influenza A
1989
·
Peter D. Reuman
, David I. Bernstein
, et al.
·
Journal of Medical Virology
·
11
Correlation of Genogroup I, Genotype 1 (GI.1) Norovirus Neutralizing Antibody Levels With GI.1 Histo-Blood Group Antigen–Blocking Antibody Levels
2024
·
Robert L Atmar
, Khalil Ettayebi
, et al.
·
The Journal of Infectious Diseases
·
6
Show more works
View as search
Works count:
18
Citation count:
1,251
H-index:
15
I10-index:
16
Year
Topic
Type
